Dear Colleague
The first update concessionary prices were granted for December 2021:
DrugPack SizeConcessionary Price
Amisulpride 50mg tablets60£2.99
Co-dydramol 10mg/500mg tablets30£3.10
Co-dydramol 10mg/500mg tablets100£6.99
Donepezil 1mg/ml oral solution sugar free150£81.23
Enalapril 10mg tablets28£5.21
Enalapril 5mg tablets28£5.87
Lamotrigine 5mg dispersible tablets sugar free28£8.50
Lansoprazole 30mg orodispersible tablets28£5.18
Lercanidipine 20mg tablets28£2.80
Loratadine 5mg/5ml oral solution100£5.85
Methocarbamol 750mg tablets100£14.89
Mirtazapine 15mg/ml oral solution sugar free66£97.89
Naftidrofuryl 100mg capsules84£7.90
Omeprazole 10mg/5ml oral suspension sugar free75£106.46
Omeprazole 20mg/5ml oral suspension sugar free75£206.00
Orlistat 120mg capsules84£23.07
Orphenadrine 50mg/5ml oral solution sugar free150£87.09
Pioglitazone 30mg tablets28£1.89
Pioglitazone 45mg tablets28£2.48
Prednisolone 5mg soluble tablets30    £11.83
Procyclidine 2.5mg/5ml oral solution sugar free150£37.39
Procyclidine 5mg/5ml oral solution sugar free150£55.61
Promazine 25mg/5ml oral solution150£60.19
Promazine 50mg/5ml oral solution150£75.36
Quetiapine 20mg/ml oral suspension sugar free150£166.31
Ramipril 2.5mg/5ml oral solution sugar free150£164.12
Ropinirole 1mg tablets84£49.50
Simvastatin 20mg/5ml oral suspension sugar free150£173.89
Simvastatin 40mg/5ml oral suspension sugar free150£250.63
Sulfasalazine 250mg/5ml oral suspension sugar free500    £94.22
Sulfasalazine 500mg tablets112£26.99
Tamoxifen 10mg/5ml oral solution sugar free150    £74.52
Timolol 0.5% eye drops5£3.02
Tolbutamide 500mg tablets28£25.09
Tolterodine 1mg tablets56£3.46
Tolterodine 2mg tablets56£3.98
Topiramate 100mg tablets60    £7.13
Topiramate 50mg tablets60£2.76
Trazodone 150mg tablets28£3.13
Trazodone 50mg capsules84    £3.45
Ursodeoxycholic acid 250mg capsules60£9.95
Warfarin 1mg/ml oral suspension sugar free150£156.07

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.

Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter. Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
DR. GARETH C. GILVARY
Governance & Support Pharmacist
Dear Colleague
Northern Ireland’s community pharmacies have administered over 250,000 COVID-19 vaccinations since the sector’s inclusion in the vaccination programme in March 2021, with nearly 83,000 attributed as booster vaccinations.
 
This is a fantastic achievement and a testament to the hard work and agility of the network and I would like to thank contractors and their teams for their dedication and commitment in supporting the COVID-19 vaccination service. CPNI issued a press release today (available HERE) to mark this important milestone and already since its release, the number of vaccinations doses have increased by at least a further 4,000.
 
These are some of busiest weeks in Community Pharmacy and community pharmacy teams will be working hard to dispense the medicines patients will need for the Christmas and new year holiday periods. To help manage public expectation, we included a reference in the press release addressing this. We have highlighted the additional pressures on the network at this time, which may affect the availability of the COVID-19 vaccination service at some community pharmacies in the lead up to and over the festive season. 

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Colleague

Please find correspondence HERE from Kathryn Turner, Pharmacy Lead, HSCB.

SUMMARY

From today, community pharmacies can administer COVID-19 booster vaccinations to:

  • Individuals aged 30 years and over for whom it has been at least 3 months since their primary vaccination course has been completed
  • HSCB will issue further correspondence as further age groupings are authorised by DoH.
  • The service specification, PGD and other relevant documentation for the COVID-19 community pharmacy vaccination service are available on the COVID-19 CPVS webpage.

ACTION

  • Contractors and pharmacists involved in the provision of this service are asked to:
    • Review the correspondence.
    • Review the updated service specification, PGD and other relevant documentation for the COVID-19 community pharmacy vaccination service are available on the COVID-19 CPVS webpage.
  • If you have any queries please contact Deirdre McAree (Deirdre.McAree@hscni.net), Katie Blair (Katie.blair@hscni.net) and Joanne Crawford (Joanne.crawford2@hscni.net).
  • Please do not hesitate to contact the CPNI office should you require any further information.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

This update contains important information for community pharmacy teams, including details of the ongoing response to the COVID-19 pandemic.

BSO ALERTS 

CPNI ALERTS 

HSCB ALERTS 

Please bring this to the attention of your pharmacy team(s).
Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via the CPNI’s Medicine Shortage Reporter or Situation Reporter.

Kind regards

SENT ON BEHALF OF 
DR. GARETH C. GILVARY
Governance & Support Pharmacist
Dear Colleague
Please find correspondence HERE from Kathryn Turner, Pharmacy Lead, HSCB.

SUMMARY

From today, community pharmacies can administer COVID-19 booster vaccinations to:

  • Individualsaged 40 years and overfor whom it has been at least3 months since their primary vaccination course has been completed
  • All patients inPriority Groups 2-9 (including adult carers) for whom it has been at least 3 months since their primary vaccination course has been completed.  Further detail on Priority Groups can be  found at Greenbook or in Appendix with this letter.
  • HSCB will issue further correspondence as further age groupings are authorised by DoH.
  • The service specification, PGD and other relevant documentation for the COVID-19 community pharmacy vaccination service are available on the COVID-19 CPVS webpage.

ACTION

  • Contractors and pharmacists involved in the provision of this service are asked to:Review the correspondence.
  • Review the updated service specification, PGD and other relevant documentation for the COVID-19 community pharmacy vaccination service are available on the COVID-19 CPVS webpage.
  • If you have any queries please contact Deirdre McAree (Deirdre.McAree@hscni.net), Katie Blair (Katie.blair@hscni.net) and Joanne Crawford (Joanne.crawford2@hscni.net).
  • Please do not hesitate to contact the CPNI office should you require any further information.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
I would like to offer my sincere thanks to all pharmacy teams who participated in the Community Pharmacy ‘Big Jab Weekend‘. Over 11,000 COVID-19 vaccinations were administered by community pharmacy across Friday, Saturday and Sunday. This is a phenomenal achievement in only three days! Community pharmacy has once again demonstrated its ability to deliver the vaccination programme for Northern Ireland. Massive congratulations to all involved! 

Community pharmacy’s hard-work and unyielding commitment to their local communities has been a long running characteristic of the network, and this has not gone unnoticed.  On Saturday, 5 December 2021, the community pharmacy workforce received the ‘Roll of Honour’ award, at the prestigious Aisling Awards, in recognition of their continued dedication to patient care throughout the past twelve months.  

This is a wonderful endorsement of the profession and again, I would like to thank community pharmacists and their teams across the network for all their hard work and commitment. 

Further information relating to the ‘Roll of Honour’ award is available HERE.

Thank you once again to you and your teams and please do not hesitate to contact CPNI Office on 028 9069 0444 for further advice or support.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive